An Uncommon Case of Bilateral Pathologic Hip Fractures: Antiviral Drug-induced Osteomalacia in a Patient with Hepatitis B
- Author:
Nam Hoon MOON
1
;
Won Chul SHIN
;
Min Uk DO
;
Hyung Joon CHO
;
Kuen Tak SUH
Author Information
- Publication Type:Case Report
- Keywords: Antiviral agents; Hypophosphatemic osteomalacia; Pathological fracture
- MeSH: Antiviral Agents; Arthralgia; Arthroplasty, Replacement, Hip; Bone Matrix; Diagnostic Errors; Fanconi Syndrome; Fractures, Spontaneous; Hepatitis B; Hepatitis; Hepatitis, Chronic; Hip Fractures; Hip; Humans; Middle Aged; Osteomalacia; Surgeons; Tenofovir
- From:Hip & Pelvis 2018;30(2):109-114
- CountryRepublic of Korea
- Language:English
- Abstract: The long-term use of adefovir and tenofovir–antiviral medications commonly used to treat chronic hepatitis B–can be associated with proximal renal tubular dysfunction resulting in significant hypophosphatemic osteomalacia. However, there have been few reports about pathological fractures requiring surgical stabilization in cases of antiviral drug-induced hypophosphatemic osteomalacia. We present the case of a 51-year-old man who sustained bilateral pathological hip fractures associated with antiviral drug-induced hypophosphatemic osteomalacia. To treat a lamivudine-resistant hepatitis-B viral infection, the patient received adefovir for 7 years followed by tenofovir for the subsequent 3 years. He had suffered from polyarthralgia and generalized weakness for 2 years prior to presentation at our clinic. Misdiagnosis and inadequate management of his condition accelerated weakness of the bone matrix and ultimately induced pathological fractures. The patient was managed via cementless total hip arthroplasty on the left hip and internal fixation on the right hip. This case highlights that orthopaedic surgeons should consider the possibility of hypophosphatemic osteomalacia if patients receiving antiviral drugs complain of polyarthralgia and generalized weakness.
